Pet Cancer Therapeutics Market on the Rise: 2024 Research Report Shows Extensive Growth and Technological Advancements - Long-term Forecast to 2028 and 2033
January 30, 2024 10:44 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Pet Cancer Therapeutics Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global pet cancer therapeutics...
Veterinary Reference Laboratory Market Analysis 2023-2028 - Strategic Initiatives Drive Moderate Consolidation, with IDEXX Laboratories and Zoetis Inc. at the Helm
January 26, 2024 06:54 ET
|
Research and Markets
Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The "Veterinary Reference Laboratory Market Size & Share Analysis - Growth Trends & Forecasts (2023-2028)" report has been added to ...
Veterinary Oncology Market Predicted to Garner $819.84 Million by 2030- Allied Market Research Report
October 26, 2021 09:59 ET
|
Allied Market Research
Portland, OR, Oct. 26, 2021 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the global veterinary oncology market was accounted for $297.30 million in 2020, and is...
ImpriMed Launches New Diagnostic Services for Canine Lymphoma
October 19, 2021 08:00 ET
|
ImpriMed, Inc.
PALO ALTO, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- ImpriMed, Inc., a leading functional precision medicine company in veterinary oncology that provides a personalized drug response profiling...
Outlook on the Veterinary Oncology Global Market to 2025 - Competitive Analysis and the Impact of COVID-19
June 17, 2021 06:53 ET
|
Research and Markets
Dublin, June 17, 2021 (GLOBE NEWSWIRE) -- The "Global Veterinary Oncology Market (2020-2025) by Type, Animal Type, Therapy Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff...
Global Veterinary Oncology Industry (2020 to 2027) - Key Market Trends and Drivers
June 10, 2021 07:48 ET
|
Research and Markets
Dublin, June 10, 2021 (GLOBE NEWSWIRE) -- The "Veterinary Oncology - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19 crisis,...
Oncology Pharma Extends Licensing Agreement with NanoSmart Pharmaceuticals, Inc. for Veterinary Oncology
February 22, 2021 08:00 ET
|
Oncology Pharma, Inc.
SAN FRANCISCO, CA, Feb. 22, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Oncology Pharma, Inc. (OTC: ONPH) is pleased to announce that it has extended a world-wide Licensing Agreement with NanoSmart...
Radiation Therapy for Pets: New Outcomes Data Presented by PetCure Oncology at Veterinary Cancer Society Annual Conference
October 22, 2019 11:05 ET
|
PetCure Oncology
Houston, TX, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Just a few weeks after celebrating the treatment of its 3,000th pet, national pet cancer care provider PetCure Oncology presented data suggesting that...
PetCure Oncology Continues to Drive Radiation Therapy for Pets with 3,000th Treatment
September 26, 2019 11:45 ET
|
PetCure Oncology
Deerfield, IL, Sept. 26, 2019 (GLOBE NEWSWIRE) -- National pet cancer care provider PetCure Oncology treated its 3,000th pet with advanced radiation therapy on Wednesday, reaching a historic...